Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control

• Kyoung-Ho Pyo,
• Kyoung-Ho Pyo,
• S. M. Mazidur Rahman,
• Diana Boraschi,
• Diana Boraschi,
• Diana Boraschi,
• Diana Boraschi

Affiliations

Kyoung-Ho Pyo

Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea

Kyoung-Ho Pyo

Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, South Korea

S. M. Mazidur Rahman

International Centre for Diarrhoeal Disease Research (iccdr,b), Dhaka, Bangladesh

Diana Boraschi

Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China

Diana Boraschi

Institute of Biochemistry and Cell Biology, National Research Council (CNR), Napoli, Italy

Diana Boraschi

Stazione Zoologica Anton Dohrn (SZN), Napoli, Italy

Diana Boraschi

China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation, Shenzhen, China